fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Maraviroc lowers incidence of graft-versus-host disease in bone marrow transplantion

Written by | 26 Oct 2012

by Bruce Sylvester – Emerging use of FDA Approved Drugs – Maraviroc, an antiretroviral drugin the treatment of HIV, significantly reduces the incidence of graft-versus-host disease (GvHD) among… read more.

ESMO 2012 Report – Urgent need for integrated oncology and palliative care

Written by | 28 Sep 2012

The European Society for Medical Oncology (ESMO) has awarded ESMO Designated Center of Integrated Oncology and Palliative Care accreditation to 16 new oncology centres.

Self-referral can increase patients’ travel distance for treatment for prostate cancer

Written by | 28 Sep 2012

Men with prostate cancer in Texas may be driving more than three times farther than needed to obtain radiation oncology treatments for their cancer when treated at a… read more.

Leading cancer specialists from Europe and beyond recognized at ESMO 2012

Written by | 28 Sep 2012

The European Society for Medical Oncology (ESMO) announced today the names of two eminent cancer specialists and one European institution that will be recognized for their contribution to… read more.

T-DM1 demonstrates overall survival benefit in metastatic breast cancer: Next target, FDA approval

Written by | 3 Sep 2012

In news that is bound to excite breast cancer patients and investors, Genentech/Roche/Immunogen issued press releases on August 26, 2012, confirming that their drug-of-the-moment T-DM1 (trastuzumab emtansine) offers… read more.

EAHP 2012 Poster Presentations – Two EAHP posters from Ireland show the benefit of ward-based clinical pharmacy services

Written by | 3 Aug 2012

by Zara Qadir – On the occasion of its 40th Anniversary, the European Association of Hospital Pharmacists (EAHP) recorded the highest number of attendees at its annual Congress… read more.

EAHP 2012 Report – Two surveys examining the role of NHS Consultant Pharmacists in the UK

Written by | 3 Aug 2012

by Zara Qadir – The role of consultant pharmacist was introduced seven years ago by the National Health Service (NHS) in the UK, with the intention of improving… read more.

EAHP 2012 Report – Report of plenary lecture – The evolution of cancer treatment

Written by | 3 Aug 2012

by Christine Clark – Changes in the diagnosis and treatment of cancer form the basis for future developments.  There have been many revolutions in medical science over the… read more.

EAHP 2012 Report – The EAHP Survey 2010 Preview

Written by | 3 Aug 2012

by Zara Qadir – Five years of evolution in Hospital Pharmacy.  The 40th EAHP meeting provided an opportunity for Tajda Miharija-Gala and Juraj Sykora, Directors of Professional Development,… read more.

EAHP 2012 Report – Compassionate use and off-label medicines

Written by | 3 Aug 2012

by Zara Qadir reporting on the presentation by Yechiel Hekster (pictured), Professor of Clinical Pharmacy, and a member of The Netherlands Medicines Evaluation Board.

New skin cancer drug cited as therapeutic breakthrough

Written by | 31 Jul 2012

by Bruce Sylvester taken from the New England Journal of Medicine (NEJM) Vismodegib (Erivedge), a new skin cancer drug for advanced basal cell carcinoma, was called “the greatest… read more.

Duloxetine relieves chemotherapy-related neuropathy

Written by | 31 Jul 2012

The antidepressant duloxetine (Cymbalta ®) can effectively treat chemotherapy-induced neuropathy in some patients , researchers reported on July 3, 2012 at the American Society of Clinical Oncology Annual… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.